[84C1-84C1];[84D2-84D2];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
84C1;84D2
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The presence of P+PBac{XP5.WH5}BSC221 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of P{XP}d11515 to be at Release 3 genomic coordinate 2933219 on chromosome arm 3R. The Gene Disruption Project determined the insertion site of P{XP}d11515 to be at Release 3 genomic coordinate 2933501 on arm 3R. This corresponds to 84C1 on both the Release 3 and Release 4 genome maps. The predicted position of PBac{WH}f00935 on the Release 4 map is 84D2. Consequently, the cytological breakpoints of Df(3R)BSC221 are predicted to be 84C1;84D2.